Search Results

Your search for Francis Paul Worden, MD matches 2 pages

Showing 1 - 2

By Francis Paul Worden, MD, and Michelle Lynn Mierzwa, MD / August 10, 2021

JAVELIN Head and Neck 100 Trial: When Failure Seems Fatal, Hope Is Not Lost

Data from KEYNOTE-048 showed that the combination of the checkpoint inhibitor pembrolizumab with platinum-containing therapy improved overall survival vs cetuximab plus chemotherapy in patients with recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).1 The findings provided hope...

solid tumors

head and neck cancer

By Francis Paul Worden, MD / February 25, 2018

Laryngeal Preservation: All Patients Need a Voice

Following the publication of two landmark studies in the United States,1,2 laryngeal preservation with combined chemoradiotherapy has become standard practice as opposed to laryngectomy for patients with locally advanced laryngeal cancer. The Department of Veterans Affairs Laryngeal Cancer Study...

Nov

Today In Oncology

Search Results

Your search for Francis Paul Worden, MD matches 2 pages

JAVELIN Head and Neck 100 Trial: When Failure Seems Fatal, Hope Is Not Lost

Laryngeal Preservation: All Patients Need a Voice

Mirdametinib in Adults and Children With Symptomatic Neurofibromatosis Type 1–Associated Plexiform Neurofibroma

Genitourinary Cancer Expert Yuksel Urun, MD, Shares His Career Journey and the Importance of Achieving a Work/Life Balance

Overall Survival Not Improved With Maintenance Niraparib in Advanced Ovarian Cancer

At-Home Testing Kits Coordinated Outreach May Improve Colorectal Cancer Screening Rates

Peer Support Intervention May Help Improve Psychological Outcomes Among Patients With Cancer in Low-Resource Settings